Close Menu

NEW YORK (GenomeWeb) – DNA chip developer Centrillion Technologies said today that it has received a multimillion US dollar investment from medical and healthcare solutions firm WeDoctor of China as part of a strategic partnership. Separately, Centrillion Technologies Taiwan said it has received a strategic investment of an undisclosed amount from the Arm IoT Fund.

Palo Alto, California-based Centrillion also recently raised at least $56 million in private placements, according to documents filed  with the US Securities and Exchange Commission last month.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.